Suggestions to India on COVID-19

COVID-19 is a preventable and easily treatable disease. However, we currently find ourselves in this bizarre situation, where the Western medical establishment became confused about COVID-19 treatment and prevention. The powers that be (including W.H.O., CDC, FDA, NIH COVID-19 Treatment Panel, and the European EMA) aggressively protect their senseless orthodoxy of not preventing or treating COVID-19. It is unclear what came first – the unprecedented establishment of this intolerant monopoly on the medical opinion or adopting absurd views as its orthodoxy. Regardless, all these organizations now share the same opinion, and hold to it without listening to the voices of practicing physicians, new research, and failure of their theories. The key element in this phenomenon is probably consumer-facing Big Tech (mainly Google[1] [2], Facebook, Twitter, and Microsoft), but this is off-topic here. Many medical journals fell to corruption and political pressures and published junk science undermining effective and inexpensive COVID-19 treatment[3] [4].

India can and should avoid more unnecessary deaths, by quickly and actively treating and preventing COVID-19, using the following effective solutions.

Pharmaceutical Interventions


At the time of this writing, India has correctly identified Ivermectin as the most effective single antiviral drug[5] against the Wuhan coronavirus. In smaller doses, the drug can also serve as prophylaxis. Of course, any antiviral should be given as early as possible. For a combined effect or a synergy against COVID-19 (sometimes combined with other opportunistic bacterial infections), Ivermectin is sometimes paired with Doxycycline.

Zinc provides additional antiviral effects, in both treatment and prophylaxis. Zinc should be taken with a Zinc ionophore, such as Quercetin or EGCG.


India was the first country to conduct a research and to recommend Hydroxychloroquine for prophylaxis of COVID-19[6]. The prophylaxis protocol has been improved by adding Zinc. There is a synergy because Hydroxychloroquine is also a Zinc ionophore.

The HCQ based COVID-19 treatment is Hydroxychloroquine + Azithromycin + Zinc, given early on symptoms. Some protocols combine Hydroxychloroquine and Ivermectin: Ivermectin + Hydroxychloroquine + Azithromycin + Zinc.

There is ongoing research into nebulized Hydroxychloroquine or Ivermectin.

The 04/28/2021 revision of MOHFW’s Guidelines for home isolation and treatment of mild (i.e., early) cases of COVID-19 do recommend Hydroxychloroquine for post-exposure prophylaxis and Ivermectin for early treatment, and inhaled Budesonide in some situations.

Some Vitamins

Vitamin C significantly improves odds against respiratory infections, including COVID-19[7]. The common mistake is to take too little of it. A typical dosage of vitamin C is 1,000 mg twice a day for prevention; 1,000 mg 3-5 times a day as part of treatment.

Vitamin D supplementation seems to be helpful[8], too.

Other pharmaceuticals

There are multiple other drugs recommended by physicians for prophylaxis and/or treatment of COVID-19.

Do NOT use Remdesivir[9]. This drug has proved to not only be useless, but also poisonous. It only received its EUA because the NIH COVID-19 Treatment Panel is corruptly[10] tied[11] to the Remdesivir manufacturer Gilead Sciences.

Some Meta-Reviews of COVID-19 Drugs – a live systematic review of Ivermectin studies – a live meta-analysis of Ivermectin studies  – a live systematic review of Hydroxychloroquine studies – a live meta-analysis of Hydroxychloroquine studies – comparison of various drugs, reviewed by the same team – collection of links and an international directory of doctors, prescribing Ivermectin

Hydroxychloroquine in Early Treatment of High-Risk COVID-19 Outpatients: Efficacy
and Safety Evidence by Harvey A. Risch, MD, PhD
Professor of Epidemiology, Yale School of Public Health


How India can reduce COVID cases and deaths, by Steve Kirsch.

“The problem is that India, like most countries, has been following the advice recommended by the recognized authorities (NIH, CDC, WHO, and EMA) for how to prevent and treat COVID.”

Not Using Ivermectin, One Year In, Is Unethical And Immoral – by TSN, January 21, 2021

Front Line COVID-19 Critical Care (FLCCC) Alliance

I-MASK+ Prevention & Early Outpatient Treatment Protocol for COVID-19PDF

Response to the Washington Pos

Real World Evidence? I-MASK+ Protocol: Ivermectin Key for Prophylaxis and Early Treatment of COVID-19 – by TSN, November 2020

FLCCC Alliance is not related to the America’s Frontline Doctors.

Many Authors

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19), Peter A. McCullough, Paul E. Alexander, … Vladimir Zelenko; Reviews in Cardiovascular Medicine, 2020


Nonpharmaceutical Interventions

Alternating Opening and Shutting Down

Instead of indefinite lockdowns, authorities would be wise to introduce short term (like two weeks) shutdowns in the areas where infections are spiking. Then, alternate between short-term opening and shutdowns. A person exposed to the Wuhan coronavirus achieves a plateau of immunity in two weeks. In the absence of symptoms, this immunity is likely to be limited, but allow the person to be exposed again with less risk (except for the elderly, of course). Also, infectious virus shedding usually stops or drops to insignificant levels within two weeks of infection. Those who do get sick, usually show symptoms and positive test results within a week. That allows authorities to detect the infection level in the middle of the two-week shutdown.

A repeating cycle of “two weeks shutdown – one week open” might be highly effective in promoting natural immunity, especially in combination with pharmaceutical prophylaxis. An absence of a spike in new cases after the open week can signal it is time for opening.

If there are festivals or other potential super-spreader events, shutting down affected areas for 5-10 days after the event might also be useful.

No Mask Mandates

Ditch mask mandates. They do not help[12] and probably harm. Even W.H.O. does not recommend universal mask wearing. The so-called social media fell in love with universal masking because it makes in-person communication unpleasant and less personable, and it serves as a constant reminder of COVID-19. This diminishes in-person communication and increases social media usage and revenues. Just look at how the revenues and market caps of Big Tech have jumped since the start of the pandemic.


  • Exposure to sunlight is necessary for optimal immunity. Some people might have had not enough of it, especially in Uttar Pradesh and other northern states. Individuals with darker skin need more exposure than those with lighter skin.
  • Higher indoor humidity and better ventilation decrease the transmission of the coronavirus indoors.
  • Ashish K. Jha is an evil idiot. Nobody should listen to him.
  • BTW, one of the internet’s downsides is that information is shared too quickly, making hard to form independent opinions, and even harder to detect informational dependencies. This problem is not limited to the science. The so-called social media exacerbates this problem.

This information is based on a great amount of peer-reviewed and published research, much of which is linked to here. It is intended to inform medical doctors and researchers, and thus help curb India’s second COVID-19 wave. I am not a medical doctor – a medical doctor would have already been under investigation for offering such shocking advice as the active treatment and/or prevention of COVID-19.

Just in (2021-05-03)

Kory, Pierre MD; Meduri, Gianfranco Umberto MD; Varon, Joseph MD; Iglesias, Jose DO; Marik, Paul E. MD. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19, American Journal of Therapeutics

1 thought on “Suggestions to India on COVID-19

Leave a Reply

Your email address will not be published. Required fields are marked *